BioSpace News Archive

Business

AbbVie Leads $53 Million Funding Round for startup Carisma Therapeutics

AbbVie Ventures, the investment arm of AbbVie, led a $53 million Series A funding round for Carisma Therapeutics and its immunotherapy CAR-Macrophage platform.

June 27, 2018
·
3 min read
·
Alex Keown
Drug Development

GBT’s Sickle Cell Drug Shows Promise in Phase III Trial

Global Blood Therapeutics (GBT) reported the results of a review of Part A of its Phase III HOPE (Hemoglobin Oxygen Affinity Modulation to Inhibit HbS PolymErization) Study of voxelotor for sickle cell disease.

June 27, 2018
·
3 min read
·
Mark Terry
Deloitte Survey Finds Biopharma Companies are Accelerating Adoption of Real-World Evidence

A recent survey shows that 90 percent of biopharma companies are making significant investments in real-world evidence capabilities to support multiple annual objectives that include driving drug development and meeting regulatory requirements.

June 27, 2018
·
4 min read
·
Alex Keown
Drug Development

Despite Being Considered Low Margin, Companies Still Go After Vaccines

The biopharma industry generally views vaccines to be low-margin investments. From a public health perspective, however, vaccines can be one of the best investment dollars.

June 27, 2018
·
5 min read
·
Mark Terry